RNF31 and Patent ductus arteriosus: Among the differentially expressed genes in CTL-treated Rnf31 or Vps4b knock-out PDA cells were several cytokines and chemokines, including the Cxcr3 ligands Cxcl9/10/11 (Supplementary Fig. 3f, g).